Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
Baird Medical Investment Holdings (NASDAQ: BDMD) recently supported a specialized microwave ablation (MWA) training program at the Columbia Thyroid Center in New York City. The two-day course, led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program, provided comprehensive instruction on MWA techniques, safety, and clinical applications.
The training attracted physicians from the US and Mexico, including Dr. Hosai Todd-Hesham and Dr. Camilo González Velázquez. Participants engaged in hands-on training with thyroid models and observed three live procedures, including the successful ablation of a 5cm thyroid nodule. The program focused on device operation, ablation precision, and real-time procedural adjustments.
This initiative is part of Baird Medical's commitment to expanding its global MWA education network and accelerating the adoption of minimally invasive treatments through standardized training and collaboration.
Baird Medical Investment Holdings (NASDAQ: BDMD) ha recentemente sostenuto un programma di formazione specializzato in ablazione a microonde (MWA) presso il Columbia Thyroid Center di New York City. Il corso di due giorni, condotto dalla Dr.ssa Jennifer Kuo, Direttore del Programma di Endocrinologia Interventistica, ha fornito istruzioni complete sulle tecniche MWA, sulla sicurezza e sulle applicazioni cliniche.
La formazione ha attirato medici provenienti dagli Stati Uniti e dal Messico, tra cui il Dr. Hosai Todd-Hesham e il Dr. Camilo González Velázquez. I partecipanti hanno svolto un addestramento pratico con modelli tiroidei e hanno osservato tre procedure dal vivo, inclusa l'ablazione riuscita di un nodulo tiroideo di 5 cm. Il programma si è concentrato sul funzionamento del dispositivo, sulla precisione dell'ablazione e sugli aggiustamenti procedurali in tempo reale.
Questa iniziativa fa parte dell'impegno di Baird Medical per espandere la propria rete di educazione MWA globale e accelerare l'adozione di trattamenti minimamente invasivi attraverso una formazione standardizzata e la collaborazione.
Baird Medical Investment Holdings (NASDAQ: BDMD) ha apoyado recientemente un programa de capacitación especializado en ablación por microondas (MWA) en el Columbia Thyroid Center de Nueva York. El curso de dos días, dirigido por la Dra. Jennifer Kuo, Directora del Programa de Endocrinología Intervencionista, proporcionó una instrucción completa sobre las técnicas de MWA, la seguridad y las aplicaciones clínicas.
La capacitación atrajo a médicos de EE. UU. y México, incluidos el Dr. Hosai Todd-Hesham y el Dr. Camilo González Velázquez. Los participantes realizaron un entrenamiento práctico con modelos de tiroides y observaron tres procedimientos en vivo, incluida la ablación exitosa de un nódulo tiroideo de 5 cm. El programa se centró en la operación del dispositivo, la precisión de la ablación y los ajustes procedimentales en tiempo real.
Esta iniciativa es parte del compromiso de Baird Medical para expandir su red de educación MWA global y acelerar la adopción de tratamientos mínimamente invasivos a través de la formación estandarizada y la colaboración.
베어드 메디컬 투자 홀딩스 (NASDAQ: BDMD)는 최근 뉴욕의 콜럼비아 갑상선 센터에서 마이크로웨이브 절제(MWA) 훈련 프로그램을 지원했습니다. 제니퍼 쿼 박사가 이끄는 이 2일 과정은 MWA 기술, 안전성 및 임상 적용에 대한 포괄적인 교육을 제공했습니다.
이번 훈련은 미국과 멕시코의 의사들을 끌어모았으며, 그 중에는 호사이 토드-헤샴 박사와 카밀로 곤잘레즈 벨라스케스 박사가 포함되었습니다. 참가자들은 갑상선 모델을 사용한 실습 교육에 참여하고, 5cm 크기의 갑상선 결절을 성공적으로 절제하는 등 세 가지 라이브 시술을 관찰했습니다. 이 프로그램은 장치 작동, 절제 정확성 및 실시간 절차 조정에 중점을 두었습니다.
이 이니셔티브는 베어드 메디컬이 전 세계 MWA 교육 네트워크를 확장하고 표준화된 교육 및 협업을 통해 최소 침습 치료의 채택을 가속화하기 위한 노력의 일환입니다.
Baird Medical Investment Holdings (NASDAQ: BDMD) a récemment soutenu un programme de formation spécialisé en ablation par micro-ondes (MWA) au Columbia Thyroid Center à New York. Ce cours de deux jours, dirigé par le Dr Jennifer Kuo, Directrice du Programme d'Endocrinologie Interventionnelle, a offert une instruction complète sur les techniques de MWA, la sécurité et les applications cliniques.
La formation a attiré des médecins des États-Unis et du Mexique, y compris le Dr Hosai Todd-Hesham et le Dr Camilo González Velázquez. Les participants ont participé à une formation pratique avec des modèles de thyroïde et ont observé trois procédures en direct, y compris l'ablation réussie d'un nodule thyroïdien de 5 cm. Le programme a mis l'accent sur le fonctionnement des dispositifs, la précision de l'ablation et les ajustements procéduraux en temps réel.
Cette initiative fait partie de l'engagement de Baird Medical à élargir son réseau éducatif MWA mondial et à accélérer l'adoption de traitements mininvasifs grâce à une formation standardisée et à la collaboration.
Baird Medical Investment Holdings (NASDAQ: BDMD) hat kürzlich ein spezialisiertes Schulungsprogramm zur Mikrowellenablation (MWA) am Columbia Thyroid Center in New York City unterstützt. Der zweitägige Kurs, geleitet von Dr. Jennifer Kuo, Direktorin des Programms für interventionelle Endokrinologie, bot umfassende Anleitungen zu MWA-Techniken, Sicherheit und klinischen Anwendungen.
Die Schulung zog Ärzte aus den USA und Mexiko an, darunter Dr. Hosai Todd-Hesham und Dr. Camilo González Velázquez. Die Teilnehmer nahmen an praktischen Schulungen mit Schilddrüsenmodellen teil und beobachteten drei Live-Verfahren, darunter die erfolgreiche Ablation eines 5 cm großen Schilddrüsenknotens. Das Programm konzentrierte sich auf die Bedienung des Geräts, die Präzision der Ablation und Echtzeitanpassungen während des Verfahrens.
Diese Initiative ist Teil des Engagements von Baird Medical, sein globales MWA-Ausbildungsnetzwerk zu erweitern und die Einführung minimalinvasiver Behandlungen durch standardisierte Schulungen und Zusammenarbeit zu beschleunigen.
- Successfully conducted specialized physician training program at prestigious Columbia Thyroid Center
- Demonstrated effective treatment of large thyroid nodules (5cm) with positive patient outcomes
- Expanding global education network to increase MWA technology adoption
- None.
Led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Program Director of the Endocrine Surgery Fellowship at
During the hands-on training session, Dr. Hesham, under the expert guidance of Dr. Kuo, performed simulated procedures using a thyroid model. She focused on mastering device operation, enhancing ablation precision, and making real-time procedural adjustments. This structured training allowed her to systematically refine her expertise in thyroid MWA, further strengthening her skills in minimally invasive techniques.
The live case observation session proved highly beneficial for the participating physicians. Through three procedures, they gained deeper insights into MWA's preoperative planning, intraoperative techniques, and postoperative patient management. The practical nature of the training received high praise from attendees. Dr. Hesham described the experience as a solid foundation that enhanced her confidence and interest in microwave ablation technology. Dr. Velázquez emphasized the irreplaceable value of hands-on clinical experience, noting that many procedural nuances extend beyond textbook knowledge. One notable case involved the ablation of a 5cm thyroid nodule, where the patient experienced significant symptom relief and a smooth recovery, further demonstrating MWA's precision and minimally invasive advantages in treating larger nodules.
As a pioneer in microwave ablation, Baird Medical is dedicated to accelerating the adoption of innovative, minimally invasive treatments through specialized training and collaboration. By expanding its global MWA education network, the Company aims to provide physicians with standardized and comprehensive training to enhance procedural expertise. Through these efforts, Baird Medical empowers more doctors to deliver safer, more effective treatments, improving outcomes and quality of life for patients worldwide.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-advances-mwa-training-with-expert-led-course-at-columbia-thyroid-center-302371852.html
SOURCE BDMD
FAQ
What was the outcome of BDMD's recent MWA training program at Columbia Thyroid Center?
How is BDMD expanding its MWA technology adoption through education?
What specific training components were included in BDMD's Columbia Thyroid Center program?
Which medical professionals participated in BDMD's February 2025 MWA training?
